Health-Related Quality of Life Effects of Modafinil for Treatment of Narcolepsy | Zendy

Kathleen Beusterien | Zendy; Ann E. Rogers | Zendy; Joyce A. Walsleben | Zendy; Hélène A. Emsellem | Zendy; Joseph A. Reblando | Zendy; Lixia Wang | Zendy; Meeta Goswami | Zendy; Bruce Steinwald | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Health-Related Quality of Life Effects of Modafinil for Treatment of Narcolepsy

Author(s) -

Kathleen Beusterien,

Ann E. Rogers,

Joyce A. Walsleben,

Hélène A. Emsellem,

Joseph A. Reblando,

Lixia Wang,

Meeta Goswami,

Bruce Steinwald

Publication year - 1999

Publication title -

sleep

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.222

H-Index - 207

eISSN - 1550-9109

pISSN - 0161-8105

DOI - 10.1093/sleep/22.6.757

Subject(s) - modafinil , narcolepsy , placebo , quality of life (healthcare) , psychology , excessive daytime sleepiness , clinical endpoint , psychiatry , medicine , randomized controlled trial , physical therapy , sleep disorder , insomnia , alternative medicine , pathology , psychotherapist

To evaluate the burden of illness of narcolepsy and assess the health-related quality-of-life (HQL) effects of oral modafinil, a wake-promoting therapy for excessive daytime sleepiness associated with narcolepsy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research